tiprankstipranks
Trending News
More News >
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market

BridgeBio Oncology Therapeutics (BBOT) Financial Statements

Compare
34 Followers

BridgeBio Oncology Therapeutics Financial Overview

BridgeBio Oncology Therapeutics's market cap is currently $963.06M. The company's EPS TTM is $; its P/E ratio is -12.98; BridgeBio Oncology Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -80.86M$ -64.77M$ 0.00$ -43.36K$ -90.84K
EBITDA$ -80.66M$ -64.68M$ -3.52K$ -43.36K$ -90.84K
Net Income$ -74.28M$ -64.70M$ -3.52K$ -43.36K$ -90.84K
Balance Sheet
Cash & Short-Term Investments$ 1.70M$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 194.42M$ 332.89K$ 144.58K$ 144.28K-
Total Debt$ 0.00$ 70.09K$ 43.11K$ 36.96K$ 0.00
Net Debt$ -1.70M$ 70.09K$ 43.11K$ 36.96K-
Total Liabilities$ 5.71M$ 396.46K$ 166.46K$ 162.64K-
Stockholders' Equity$ 188.72M$ -63.57K$ -21.88K$ -18.36K$ 112.48M
Cash Flow
Free Cash Flow$ -763.82K$ 0.00$ 0.00$ 0.00$ -316.69K
Operating Cash Flow$ -763.82K$ 0.00$ 0.00$ 0.00$ -316.69K
Investing Cash Flow$ -184.00M$ 0.00$ 0.00$ 0.00$ -115.00M
Financing Cash Flow$ 186.46M$ 0.00$ 0.00$ 0.00$ 116.65M
Currency in USD

BridgeBio Oncology Therapeutics Earnings and Revenue History

BridgeBio Oncology Therapeutics Debt to Assets

BridgeBio Oncology Therapeutics Cash Flow

BridgeBio Oncology Therapeutics Forecast EPS vs Actual EPS